A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Documenti analoghi

• Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
  di: Alda Daniela García‐Guzmán, et al.
  Pubblicazione: (2025)
• Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
  di: Ashley C. Holland, et al.
  Pubblicazione: (2025)
• Late Onset Blinatumomab‐Related Neurotoxicity in a Child With B‐Cell Acute Lymphoblastic Leukemia
  di: Krunal Shah, et al.
  Pubblicazione: (2025)
• Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
  di: Nirali N. Shah, et al.
  Pubblicazione: (2025)
• Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
  di: Andrew E. Place, et al.
  Pubblicazione: (2025)